| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3316614 | Pancreatology | 2013 | 6 Pages |
Abstract
Using a transgenic mouse model that recapitulates human pancreatic cancer, this study provides first evidence that simvastatin is an effective chemopreventive agent by delaying the progression of PanINs and partially inhibit the formation of murine pancreatic cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Volker Fendrich, Moritz Sparn, Matthias Lauth, Richard Knoop, Lars Plassmeier, Detlef K. Bartsch, Jens Waldmann,